arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1906.07511q-bio.NCq-bio.TO
收藏

ADAM30通过激活组织蛋白酶D下调阿尔茨海默病中APP相关缺陷

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease

Florent Letronne, Geoffroy Laumet, Anne-Marie Ayral, Julien Chapuis, Florie Demiautte, Mathias Laga, Michel Vandenberghe, Nicolas Malmanche, Florence Leroux, Fa… 展开作者

Florent Letronne, Geoffroy Laumet, Anne-Marie Ayral, Julien Chapuis, Florie Demiautte, Mathias Laga, Michel Vandenberghe, Nicolas Malmanche, Florence Leroux, Fanny Eysert, Yoann Sottejeau, Linda Chami, Amandine Flaig, Charlotte Bauer, Pierre Dourlen, Marie Lesaffre, Charlotte Delay, Ludovic Huot, Julie Dumont, Elisabeth Werkmeister, Franck Lafont, Tiago Mendes, Franck Hansmannel, Bart Dermaut, Benoit Deprez, Anne-Sophie Herard, Marc Dhenain, Nicolas Souedet, Florence Pasquier, David Tulasne, Claudine Berr, Jean-Jacques Hauw, Yves Lemoine, Philippe Amouyel, David Mann, Rebecca Déprez, Frédéric Checler, David Hot, Thierry Delzescaux, Kris Gevaert, Jean-Charles Lambert

摘要:

虽然几种ADAM(A解整合素样和金属蛋白酶)已被证明有助于淀粉样前体蛋白(APP)代谢,但参与这种代谢的金属蛋白酶的全谱仍有待建立。以金属蛋白酶基因为中心的转录组学分析揭示了ADAM 30表达减少50%,这与阿尔茨海默病大脑中的淀粉样蛋白负荷呈负相关。因此,在体外下调或上调ADAM 30的表达触发了A $β$肽水平的增加/减少,而生物学上无活性的ADAM 30(ADAM 30 mut)的表达不影响A $β$的分泌。蛋白质组学/基于细胞的实验表明,APP代谢的ADAM 30依赖性调节需要组织蛋白酶D(CTSD)激活和APP分选到溶酶体。因此,在阿尔茨海默样转基因小鼠中,神经元ADAM 30过表达降低神经元原代培养物中的A $β$ 42分泌、脑中的可溶性A $β$ 42和淀粉样斑块负荷水平,并伴随增强CTSD活性,最终挽救长时程增强。

英文摘要:

Although several ADAMs (A disintegrin-like and metalloproteases) have been shown to contribute to the amy-loid precursor protein (APP) metabolism, the full spectrum of metalloproteases involved in this metabolism remains to be established. Transcriptomic analyses centred on metalloprotease genes unraveled a 50% decrease in ADAM30 expression that inversely correlates with amyloid load in Alzheimer's disease brains. Accordingly, in vitro down-or up-regulation of ADAM30 expression triggered an increase/decrease in A$β$ peptides levels whereas expression of a biologically inactive ADAM30 (ADAM30 mut) did not affect A$β$ secretion. Proteomics/cell-based experiments showed that ADAM30-dependent regulation of APP metabolism required both cathepsin D (CTSD) activation and APP sorting to lysosomes. Accordingly, in Alzheimer-like transgenic mice, neuronal ADAM30 over-expression lowered A$β$42 secretion in neuron primary cultures, soluble A$β$42 and amyloid plaque load levels in the brain and concomitantly enhanced CTSD activity and finally rescued long term potentiation.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑